Navigation Links
Experimental drug shows encouraging results in treating most common form of lung cancer
Date:11/1/2013

An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among men and women worldwide.

Dr. Edward Garon, director of thoracic oncology at UCLA's Jonsson Comprehensive Cancer Center, presented the preliminary results of a Phase 1B study of the new drug, called MK-3475, on Oct. 29 at the World Conference on Lung Cancer in Sydney, Australia.

The detailed interim data on safety and activity came from a cohort of 38 patients with non-small cell lung cancer who were treated previously for the disease without positive results. For the study, the patients received MK-3475 every three weeks.

Among the participants, 24 percent responded to the drug, with their tumors shrinking, and the median overall survival rate was 51 weeks. For those who responded, the median response duration the average amount of time their tumors remained shrunk had not been reached at the time of this analysis, so it is at least 62 weeks.

Based on this data, a Phase 2/3 trial comparing two different doses of MK-3475 to standard chemotherapy for lung cancer has begun enrolling patients.

Some cancer cells can evade detection by the immune system by expressing a protein called PD-L1, which interacts with the protein PD-1 to prevent the immune system from seeing the cancer as an invader. MK-3475, an anti-PD-1 immunotherapy drug made by Merck, allows the immune system to properly detect the cancer and to activate T cells the so-called "foot soldiers" of the immune system to attack and kill cancer cells.

The most commonly reported drug-related side effects in the study were rash (21 percent), skin itching (18 percent), fatigue (16 percent), diarrhea (13 percent) and joint pain (11 percent). Most side effects, however, were of low grade.

"These are early results,
'/>"/>

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant
2. ASSURE study of experimental agent to raise HDL yields disappointing and surprising results
3. York physicists offer novel insight into experimental cancer treatment
4. Experimental Drug Shows Benefits Against Melanoma in Early Study
5. Experimental Drugs Show Promise Against Prostate Cancer
6. Experimental Drug Seems to Aid Memory in Mice With Alzheimers
7. Mayo Clinic finds experimental drug inhibits growth in all stages of common kidney cancer
8. Experimental Drug for Hepatitis C Promising, Studies Show
9. Experimental Vaccine Shows Promise for Ovarian Cancer
10. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
11. Experimental Staph Vaccine Fails to Work, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... The Plastic Surgery Group (PSG) is ... even in the U.S. to provide clients with Vanquish, ... patients’ waists with deep-tissue heating. , Unlike Cryotherapy which ... is more inclusive to target large sections of desired ... panels about one inch away from their body while ...
(Date:8/30/2014)... New Delhi, India (PRWEB) August 30, 2014 ... has introduced low cost SEO service for small businesses. ... businesses or start-ups cannot afford costly search engine optimization ... the budget of small businesses into account. , ... executive said, “We have introduced this low cost SEO ...
(Date:8/30/2014)... The establishment and creation of ... one of the main strategies of the Church ... impact around the world. , Architecturally stellar buildings ... executives and trainers deliver L. Ron Hubbard's spiritual ... statistics demonstrate that significant reduction in crime, major ...
(Date:8/30/2014)... is a common problem millions of American cope with every day. ... nuisance, for some, it can have a crippling impact on social ... dramatic mood swings and depression. , Those struggling with acne ... In some cases, that can make the problem even worse. Instead ... a quest for clearer skin can now view acne treatment ...
(Date:8/30/2014)... Seniors Guide, the comprehensive guide to all things senior, ... Disease, Dementia, and Memory Loss . , Country singer Glen ... with the Alzheimer’s, inspired Seniors Guide writers to review the ... movie, out on October 14, 2014, shows a glimpse of ... disease – which inspires a final tour from the musician ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2
... with GlaxoSmithKline,s Advair and,Boehringer Ingelheim/Pfizer,s Spiriva, Significant ... According to a New Report from Decision ... Decision Resources, one of the,world,s leading research ... issues, finds that surveyed physicians indicate that ...
... Demand for Biotech-Based Materials, Fuel, ... ... (NYSE: DD ),today announced leadership changes to strengthen its leading ... based innovations in materials, food, feed and fuel markets., "Across ...
... Increased High-Performance ... and Academia, SOUTHPOINTE, Pa., Feb. 27 ... of simulation software and technologies,designed to optimize product ... Science and Technology Information (KISTI), one of,the world,s ...
... Delivery Plan Completely Customized for alli(R) ... ... eDiets.com,Inc. (Nasdaq: DIET ), leveraging the power of technology ... the,immediate availability of its fresh meal delivery program specially,designed to coordinate ...
... Israel, Feb. 27 Shamir,Optical Industry Ltd. (Nasdaq: ... year end 2007 earnings results on Thursday, March 6, ... results at 9:00 A.M. EST,that morning., The conference ... To,listen live, please go to http://www.kcsa.com approximately ...
... with normal blood glucose (sugar) levels showed elevated markers for ... type 2 diabetes and cardiovascular disease, says a new study ... study, published in the March issue of Diabetes Care, is ... be at high risk for developing type 2 diabetes as ...
Cached Medicine News:Health News:A Once-Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD-Related Inflammation Could Achieve Blockbuster Status 2Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 2Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 3Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 4Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 2Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 3Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 4Health News:eDiets(R) Launches Fresh Meal Delivery Program for alli(R) Users 2Health News:eDiets(R) Launches Fresh Meal Delivery Program for alli(R) Users 3Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2007 Earnings Results 2Health News:Overweight Hispanic children shown to have vascular inflammation 2
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)... Research and Markets has announced ... Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the aspects ... and business performance of domestic major enterprises, as well ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... BD Beaver Clear Cornea Incision System ... specifically for the Cataract surgeon. The System ... an alternative to costly diamond knives. ... shield that is designed to both protects ...
... Built on the market leading optical ... 500 has been optimized for even better ... illumination system, including a new XHL Xenon ... the cornea and clear, high resolution images ...
The NIAGARA Thermal Retention System (TRS) maintains the temperature of prewarmed irrigation fluid continuously as it is delivered through the Corson®, Surgiflex® WAVE™, or Surgiflex D...
... the EZ Meter and press the measurement ... measurement results on its large color LCD ... printout makes this the ideal instrument for ... addition to being extremely easy-to-use, the EZ-200 ...
Medicine Products: